Aimovig
My Prescription
Payment
Select pharmacy
$770.07
Print or send this coupon to your phone
AlbertsonsPowered byAbout Aimovig
Drug Details
Aimovig (erenumab) is specifically designed to prevent migraines in adults. It is administered once a month via an injection under the skin, using a prefilled autoinjector or syringe. This medication is part of the monoclonal antibodies class and works by blocking calcitonin gene-related peptide (CGRP) receptors in the brain and nervous system, which are thought to be involved in pain signaling and migraine symptoms. By inhibiting these receptors, Aimovig helps reduce the frequency of migraine attacks, thereby enhancing your ability to focus and carry out daily activities. Some individuals may experience side effects such as pain, swelling, or redness at the injection site, as well as constipation. Always consult with your healthcare provider to ensure Aimovig is appropriate for your needs.
Price history for Aimovig
1 Pen, 1ML of 140MG/ML
Average retail price for Aimovig
Average SaveHealth price for Aimovig
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Aimovig dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 1ML of 140MG/ML | 1 Pen | $770.27 | $770.27 |
| 1ML of 70MG/ML | 1 Pen | $770.14 | $770.14 |
| 1ML of 70MG/ML | 2 Pens | $1,523.27 | $761.64 |
| 1ML of 70MG/ML | 3 Pens | $2,276.41 | $758.80 |
| 1ML of 140MG/ML | 2 Pens | $1,523.54 | $761.77 |
| 1ML of 140MG/ML | 3 Pens | $2,276.81 | $758.94 |
Aimovig FAQs
Aimovig has not been discontinued. It is still available as a treatment option for the prevention of migraines. If there are any concerns about its availability or specific issues related to its use, it is advisable to consult a healthcare provider or pharmacist for the most current information.
Aimovig is a medication used to prevent migraines. It works by blocking the activity of a protein called calcitonin gene-related peptide (CGRP), which is involved in migraine attacks. By inhibiting this protein, Aimovig helps reduce the frequency and severity of migraine episodes.
Aimovig (erenumab) is not commonly associated with weight gain. While weight changes are not listed as a typical side effect, individual responses to medication can vary. If there are concerns about weight changes while taking Aimovig, it is advisable to consult with a healthcare provider.
The effectiveness of Emgality versus Aimovig can vary depending on the individual. Both medications are used for the prevention of migraines and belong to the same class of drugs known as CGRP inhibitors. Some patients may respond better to one medication over the other due to differences in their body chemistry or the specific nature of their migraines. It is important for patients to consult with their healthcare provider to determine which medication may be more effective for their specific condition.
Bloating is not commonly reported as a side effect of Aimovig (erenumab). However, side effects can vary among individuals. If someone experiences bloating or any other unusual symptoms while taking Aimovig, it is advisable to consult with a healthcare provider for further evaluation and guidance.